Sign in
4/A

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000950170-23-032730

Chief Scientific Officer sold 1,384 shares at $0.34 ($471)

  • Chief Scientific Officer acquired 150,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-04 Exercise or conversion : show line 1 in the form 10b5-1 +150,000 200,050 D
2023-07-06 Sale : show line 2 in the form 10b5-1 −1,384 $0.34 $471 198,666 D
Open-market sales · 1,384 sh · avg $0.34 · $471

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2023-07-04 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit −150,000 150,000 0 D
Loading xslF345X04/ownership.xml…